Figure 3.
Clinical impact of PRC2 alterations in the GRAALL-2003-2005 studies. (A) Overall survival and (B) cumulative incidence of relapse in the GRAALL-2003-2005 studies. Red curves represent the PRC2-altered T-ALL, and blue curves the WT patients.

Clinical impact of PRC2 alterations in the GRAALL-2003-2005 studies. (A) Overall survival and (B) cumulative incidence of relapse in the GRAALL-2003-2005 studies. Red curves represent the PRC2-altered T-ALL, and blue curves the WT patients.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal